Table 2.

GCLQ scores ≥4 points and LVC ≥10% from basement plus patient-reported LLE diagnosis.

	Leg volume change	GCLQ change	No lymphedema on GCLQ		Lymphedema on GCLQ		Total
Disease site			No Treatment	Treatment	No Treatment	Treatment	N	%
Cervix (n = 136)	<10%	<4	51	.	.	.	51	38
		≥4	24	.	3	10	37	27
	≥10%	<4	17	.	.	2	19	14
		≥4	20	.	2	7	29	21
Endometrium (n = 719)	<10%	<4	289	6	1	8	304	42
		≥4	138	3	7	23	171	24
	≥10%	<4	123	4	1	4	132	18
		≥4	72	2	4	34	112	16
Vulvar (n = 39)	<10%	<4	6	.	.	1	7	18
		≥4	10	.	1	5	16	41
	≥10%	<4	4	.	.	.	4	10
		≥4	4	.	2	6	12	31
Total (n = 894)	<10%	<4	346	6	1	9	362	40
		≥4	172	3	11	38	224	25
	≥10%	<4	144	4	1	6	155	17
		≥4	96	2	8	47	153	17

^**Definition of LLE is a LV increase ≥ 10% and GCLQ score ≥ 4 change from baseline with any individual reporting a formal diagnosis of LLE.